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Introduction: Primordial germ cells (PGCs) are the major population of cells in the developing bilateral embryonic
gonads. Little is known about the cellular responses of PGCs after treatment with toxic chemicals such as busulfan
during embryo development. In this study, we investigated the elimination, restorative ability, and cell cycle status
of endogenous chicken PGCs after busulfan treatment.
Methods: Busulfan was emulsified in sesame oil by a dispersion-emulsifying system and injected into the chick
blastoderm (embryonic stage X). Subsequently, we conducted flow cytometry analysis to evaluate changes in the
PGC population and cell cycle status, and immunohistochemistry to examine the germ cell proliferation.
Results: Results of flow cytometry and immunohistochemistry analyses after busulfan treatment showed that the
proportion of male PGCs at embryonic day 9 and female PGCs at embryonic day 7 were increased by
approximately 60% when compared with embryonic day 5.5. This result suggests the existence of a compensatory
mechanism in PGCs in response to the cytotoxic effects of busulfan. Results of cell cycling analysis showed that the
germ cells in the G0/G1 phase were significantly decreased, while S/G2/M-phase germ cells were significantly
increased in the treatment group compared with the untreated control group in both 9-day-old male and female
embryos. In addition, in the proliferation analysis with 5-ethynyl-2′-deoxyuridine (EdU) incorporation, we found that
the proportion of EdU-positive cells among VASA homolog-positive cells in the 9-day embryonic gonads of the
busulfan-treated group was significantly higher than in the control group.
Conclusions: We conclude that PGCs enter a restoration pathway by promoting their cell cycle after experiencing
a cytotoxic effect.Introduction
The continuous maintenance of future generations in liv-
ing organisms is preserved by germ cell development.
Thus, germ cell research is important to advance infertility
treatments and perform developmental studies. Elimin-
ation of endogenous germ cells has been widely used in
germ cell transplantation studies (for clinical purposes)
and germline chimera production (for research purposes).
Several methods, including gamma ray irradiation, X-ray
irradiation [1-3], and busulfan administration [4-6], have* Correspondence: jaehan@snu.ac.kr
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reproduction in any medium, provided the orbeen developed to eliminate endogenous germ cells in dif-
ferent vertebrate species. These methods primarily induce
DNA damage in target cells, resulting in loss of all cellular
mechanisms and ultimately cell destruction. Busulfan is
an alkylating agent that can induce target cell apoptosis
when administered to cells or tissues. Until recently,
busulfan treatment was the preferred method of elimin-
ating germ cells. Although busulfan administration can
induce side effects including lethality, sterility and
teratogenicity [7], the majority of studies have applied
busulfan to eliminate germ cells in mouse and rat testis
because of its relatively higher cytotoxicity to target
cells. After busulfan administration, testicular germ
cells undergo apoptosis; however, small populations of
spermatogonial stem cells survive in mice [8]. These. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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restoration of the germ cell population after reduction
or withdrawal of busulfan toxicity [9].
Primordial germ cells (PGCs) are the precursors of
germ cells in most vertebrates and play an important
role in early embryonic germ cells [10]. Elimination of
PGCs by busulfan administration can be performed in
early chicken embryos because isolation and manipula-
tion of PGCs from these embryos is simple compared
with other vertebrate embryos. In chickens, PGCs ori-
ginate in the epiblast and migrate through the hypoblast
and blood to reach embryonic gonads. Busulfan admin-
istered to chicken eggs at Eyal-Giladi and Kochav stage
X [11] successfully eliminated all endogenous PGCs
in the embryos. After busulfan treatment, donor PGCs
injected into the embryos migrated and colonized on
the recipient gonads. The proportion of donor-derived
offspring was also increased significantly [5,12]. How-
ever, little is known about the cellular responses of
PGCs after busulfan treatment. In the present study, we
conducted flow cytometric analysis to evaluate changes in




The care and experimental use of chickens were ap-
proved by the Institute of Laboratory Animal Resources,
Seoul National University (SNU-070823-5). White Leg-
horn chickens were maintained according to a standard
management program at the University Animal Farm,
Seoul National University, Korea. The procedures for
animal management, reproduction, and embryo manipu-
lation adhered to the standard operating protocols of
our laboratory.
Survival and hatching rates
To measure survival rates, egg candling was performed
for each egg during the observation period. Properly de-
veloping eggs were identified based on the clear demar-
cation of light and dark side within the egg and the
formation of a network of blood vessels reaching toward
the air space. Unfertilized eggs at day 3 were removed
from the data and hatching of the eggs occurred at ap-
proximately day 21.
Busulfan emulsification
Emulsification of busulfan and injection into chicken em-
bryos was performed as described by Nakamura and col-
leagues [5], with minor modifications. A schematic diagram
of busulfan emulsification and injection into eggs is shown
in Figure 1. Approximately 40 mg busulfan (Sigma-Aldrich,
St Louis, MO, USA) were dissolved in 1 mlN,N-dimethyl
formamide (Merck, Darmstadt, Germany) and diluted 10-fold in phosphate-buffered saline (PBS). For emulsification,
an internal pressure micro kit (IMK-20; MCtech, Siheung,
Korea) was used as a dispersion-emulsifying system with a
tube-shaped Shirasu porous glass (SPG; pore diameter,
10 μm) membrane. The dispersed phase inside the SPG
membrane was filled with busulfan-solubilized solution,
and the continuous phase outside the SPG membrane
was filled with the same volume of sesame oil (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA) with
1% polyglycerol polyricinoleate (PGPR90; Danisco,
Denmark) (Figure 2). The internal pressure was injected
using nitrogen gas while stirring the continuous phase
with a rotator. The final concentration of busulfan in
the emulsion was 2 μg/μl in sesame oil containing 1%
PGPR90. To optimize the concentration of PGPR90, par-
ticle size uniformity and the color of the emulsified solu-
tion with different concentrations of PGPR90 were
observed at time 0 and 1 day after emulsification. Newly
laid White Leghorn eggs at Eyal-Giladi and Kochav stage
X were placed horizontally 1 hour before injection. The
optimal dose of busulfan was determined based on Naka-
mura and colleagues [5]. A small hole was made at the
sharp end of eggs to avoid air cell damage and 50 μl busul-
fan emulsion (100 μg busulfan) were injected into the yolk
under the blastoderm through a small hole using a sharp
needle. After injection, the hole was sealed and the eggs
were incubated at 37°C with 50 to 60% relative humidity
until the gonads were isolated at embryonic days 5.5, 7, 9
and 15.
5-Ethynyl-2′-deoxyuridine incorporation
To examine the proliferation activity of germ cells, ap-
proximately 10 μl of 10 mM 5-ethynyl-2′-deoxyuridine
(EdU) in PBS was injected into the extra-embryonic
blood vessels 4 hours before embryonic day 9. After in-
jection, the eggs were sealed with Parafilm and incu-
bated until the completion of embryonic day 9.
Immunohistochemistry
After collection of 5.5-day-old and 9-day-old embryos
treated with busulfan at stage X, the abdomen of the
embryos was carefully dissected under a stereomicro-
scope and the gonads were collected with sharp tweezers
[13]. Whole gonads were then cryosectioned (thickness,
10 μm) or paraffin-sectioned (thickness, 6 μm) and
stored for immunostaining. For the immunostaining
analysis, gonadal sections (after deparaffinization for
paraffin-sectioned tissues) were washed three times with
PBS and blocked with blocking buffer, which was com-
posed of PBS containing 5% goat serum and 1% bovine
serum albumin, for 1 hour at room temperature. Sec-
tions were then incubated at 4°C overnight with rabbit
anti-cVASA (chicken VASA homolog) antibody to detect
germ cells. After washing three times with PBS, sections
Figure 1 Schematic diagram of the methods for busulfan emulsification and injection into eggs. (A) Internal pressure-type micro kit (IMK-
20; MCtech, Siheung, Korea). (B) Busulfan solubilized in 10% N,N-dimethylformamide in phosphate-buffered saline. (C) Hydrophobic membrane
with 10-μm pore diameter. (D) Sesame oil with polyglycerol polyricinoleate. (E) Sharp needle. (F) Blastoderm. (G) Egg yolk. (H) Egg white. (I)
Air space.
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phycoerythrin (PE) or fluorescein isothiocyanate (Santa
Cruz Biotechnology) for 4 hours at room temperature.
To detect incorporated EdU, sections were further
stained for Click-iT detection with Alex Fluor 594Figure 2 Increase in particle size uniformity according to polyglycero
sesame oil containing various polyglycerol polyricinoleate concentrations. (
(scale bar = 100 μm).(C10339; Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s instructions. Sections were then
mounted with Prolong Gold anti-fade reagent with 4',6-
diamidino-2-phenylindole (Invitrogen, Carlsbad, CA,
USA) and visualized using fluorescence microscopy.l polyricinoleate concentration. (A) Solution feature emulsified with
B) Particle size uniformity after emulsification and after 1 day
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For flow cytometry, whole gonads from busulfan-treated
embryos at day 5.5, day 7, day 9 and day 15 were disas-
sociated by gentle pipetting in 0.05% (v/v) trypsin solu-
tion supplemented with 0.53 mM ethylenediamine
tetraacetic acid, fixed with 4% paraformaldehyde and
permeabilized. Cells were then suspended in PBS con-
taining 1% bovine serum albumin and strained through
a cell strainer (40 μm, BD Falcon; Becton Dickinson,
Franklin Lakes, NJ, USA). Cell aliquots were incubated
in 500 μl of 1% bovine serum albumin in PBS containing
primary antibodies (chicken VASA) on ice for 30 mi-
nutes. After washing with PBS, cells were incubated in
fluorescein isothiocyanate-conjugated secondary anti-
bodies on ice for another 20 minutes. For cell cycle ana-
lysis, RNase treatment and propidium iodide staining
were performed. Flow cytometry was performed on a
FACSAria III (Becton Dickinson). All subsequent ana-
lyses were performed using FlowJo software (Tree Star,
Ashland, OR, USA) and Modifit LT cell cycle analysis
software (Verity Software House, Topsham, ME, USA).
Statistical analysis
Statistical analysis was performed using Student’s t test
in the SAS version 9.3 software (SAS Institute, Cary,
NC, USA). The significance of differences between con-
trol and treatment groups was analyzed using the gen-
eral linear model (PROC-GLM) in the SAS software.
Differences between treatments were considered signifi-
cant at P <0.05.
Results
Emulsification conditions for busulfan with PGPR90 by IMK-20
For efficient emulsification of busulfan, PGPR90 was used
as an emulsifier. The particle size uniformity was observed
under the microscope to confirm the effect of 0.0 to 10.0%
PGPR90 on emulsification (Figure 2A). Emulsification did
not occur with 0% PGPR90, whereas very low-level emul-
sification was observed with 0.1% of PGPR90. With 1%,
5% and 10% PGPR90, the particle size uniformity was
maintained even after 24 hours (Figure 2B).
Survival and hatching rate of the chicken embryos after
busulfan treatment
To evaluate teratogenic effects of busulfan treatment, we





Day 3 Day 7 D
Untreated controls (0) 71 94.47 ± 1.08 92.96 ± 1.41 89.9
Busulfan treated (100) 144 87.03 ± 3.16 77.65 ± 3.36 69.7
P value 0.0902 0.0136 0embryonic development. The survival rates of the busul-
fan treatment group were significantly lower than those
of the untreated control group during development. The
survival rates of the control and busulfan-treated groups
showed no differences at day 3 but were significantly
lower in the busulfan-treated group after 7 days of in-
cubation (P <0.05). Upon hatching, the survival rates of
the two groups were significantly different (P <0.01)
(Table 1). Mean hatching rates of the untreated control
and busulfan treatment groups were 84.47 ± 1.49% (n = 3,
total events = 71) and 61.85 ± 2.59% (n = 3, total events =
144), respectively.
Elimination and restoration of PGCs after busulfan
treatment
Depletion of PGCs after busulfan treatment was investi-
gated by immunohistochemistry. Whole gonads were col-
lected at embryonic days 5.5 and 9 in both sexes and
cryosectioned prior to immunostaining. To identify germ
cells, an anti-VASA primary antibody and PE-conjugated
secondary antibody were used. At day 5.5, numerous
VASA-positive PGCs were dispersed in the gonads of the
male and female control group (Figure 3). However, the
number of VASA-positive PGCs was greatly decreased in
male and female gonads of the busulfan-treated group. At
day 9, VASA-positive germ cells were dispersed through-
out the male gonads and dispersed in the cortex region
of female gonads. In the busulfan-treated group, few
VASA-positive germ cells were observed in male
and female gonads. Furthermore, the number of VASA-
positive germ cells in busulfan-treated female gonads at
day 9 was slightly higher than that of busulfan-treated fe-
male gonads at day 5.5 (Figure 3).
To examine the proportion of PGCs after busulfan
treatment, VASA-positive cells in the embryonic gonads
were analyzed by flow cytometry. The mean proportions
of PGCs normalized to control PGCs in whole gonads at
days 5.5, 7, 9 and 15 are shown in Figure 4. In day 5.5
embryonic gonads, the proportion of PGCs was de-
creased significantly after busulfan treatment (male, 24%;
female, 8%; normalized to control, n = 3). In day 7, 9 and
15 embryonic gonads, the proportion of PGCs was also
decreased significantly after busulfan treatment (male,
23%, 60% and 71%, respectively; female, 67%, 60% and
65%, respectively, normalized to control, n = 3). The
rates of VASA-positive PGCs in all busulfan-treatedbusulfan treatment
of embryos on incubation day (%) Hatched
(%)ay 10 Day 14 Day 17 Day 20
3 ± 4.17 88.64 ± 3.99 88.64 ± 3.99 85.91 ± 2.81 84.47 ± 1.49
5 ± 4.93 68.39 ± 5.31 68.39 ± 5.31 67.65 ± 5.01 61.85 ± 2.59
.0354 0.0381 0.0381 0.0336 0.0016
Figure 3 Elimination and restoration of endogenous primordial germ cells in embryonic gonads by busulfan treatment at stage X.
Immunostaining was performed to detect germ cells in 5.5-day-old and 9-day-old embryonic gonads using an anti-VASA primary antibody and
PE-conjugated secondary antibody. Scale bar = 100 μm.
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significantly lower than those in the control groups
(P <0.001) (Figure 4). However, the proportion of PGCs
in the busulfan treatment group was significantly increased
at embryonic day 9 in male embryos and at embryonic day
7 in female embryos compared with embryonic day 5.5
(Figure 4). Consistent with this germ cell recovery phe-
nomenon, chickens in the busulfan-treated group pro-
duced functional sperms or eggs when they reached sexual
maturity (n = 5 for male and n = 3 for female).Cell cycle regulation after busulfan treatment
To examine changes in the cell cycle of PGCs during
the recovery period after busulfan treatment, the cell
cycle in VASA-positive PGCs of day 9 gonads was evalu-
ated by flow cytometry using propidium iodide staining.
Representative and replicate cell cycle results in the
PGCs of day 9 gonads after busulfan treatment are
shown in Figure 5A and 5B, respectively. In both males
and females, the proportion of PGCs in the quiescent
phase (G0/G1) of the busulfan treatment group was sig-
nificantly decreased compared with the control group
(male, 74.03 ± 0.68% to 68.65 ± 1.27%; female, 63.13 ± 1.03%
to 58.17 ± 0.61%, n = 3). In contrast, the proportion of
PGCs in the proliferative phase (S/G2/M) of the busulfan-
treated group was significantly increased compared with
the control group (male, 25.91 ± 0.68% to 31.35 ± 1.27%; fe-
male, 36.87 ± 1.03% to 41.83 ± 0.61%, n = 3). The propor-
tion of PGCs in the sub-G1 phase did not show significant
changes between two groups in both males and females.Proliferation of restored PGCs after busulfan treatment
To examine proliferation activity of the restored PGCs
in the busulfan-treated group, EdU-incorporated 9-day-old embryonic gonads were isolated and immunostained
with anti-VASA and EdU. Results showed that EdU-
incorporated cell nuclei in the male and female gonads
of busulfan-treated groups were increased when com-
pared with control groups (Figure 6A). Furthermore, we
investigated the number of proliferating germ cells by
counting the number of EdU-positive cells among
VASA-positive cells. The number of proliferating germ
cells increased by about 15% in busulfan-treated male
gonads compared with the control. Similarly, the number
of proliferating cells increased by about 30% in busulfan-
treated female gonads (Figure 6B).Discussion
To eliminate endogenous PGCs in chickens by busulfan
treatment, a sustained-release emulsion of busulfan
using an SPG pumping connector was used in a previous
study [5]. Here, we modified the emulsion methods
using an internal pressure micro kit with a tube-shaped
SPG membrane and PGPR90. Using this method, we
could simplify the preparation of solubilized busulfan
and obtain an increased hatching rate (61.85%) in the
busulfan treatment group when compared with previous
studies that used the same busulfan dose [5].
Busulfan, an alkylating agent, has been used for clinical
studies of chronic myelogenous leukemia and bone mar-
row transplantation [14,15]. Generally, busulfan targets
slowly proliferating and nonproliferating cells. The
mechanism of action of busulfan has been identified as
DNA alkylation leading to DNA–DNA cross-linking
[16], which causes cell death and/or cellular senescence
through the ERK and p38 pathways. Busulfan also func-
tions as a mitogen-activated protein kinase [17]. Conser-
vation of antimitotic pathway across various cell types
Figure 4 Proportion of primordial germ cells (PGCs) in the embryonic gonads after busulfan treatment at stage X. (A) Representative
flow cytometry dot plots of day 5.5, day 7, day 9 and day 15 embryonic gonadal cells labeled with anti-VASA. (B) Proportion of PGCs in the em-
bryonic gonads of the busulfan-treated group. Data were normalized to the proportion of PGCs in the control. Bars indicate standard error of the
mean of triplicate analyses. ***P <0.001, significant difference compared with control.
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germ cells in embryonic gonads or testes, leading to the
depletion of endogenous germ cells. PGCs, which are a
precursor of gametes, may therefore be a major targetfor the germ cell depletion and sterilization. To target
PGCs, busulfan should be administered at very early em-
bryonic stages during which PGCs are formed. There
are about 30 PGCs in the blastoderm of a fertilized hen
Figure 5 Cell cycle analysis in primordial germ cells of 9-day-old embryonic gonads after busulfan treatment at stage X. VASA-positive
cell populations in embryonic gonads derived from flow cytometry were evaluated in terms of cell cycle phase. (A) Results of representative cell
cycle evaluations in males and females. (B) Results of replicate cell cycle evaluations in males and females. Bars represent the standard error of
the mean of triplicate analyses. *P <0.05, significant difference compared with control.
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PGC-mediated germline chimeras by direct injection
into blastoderm of fertilized eggs in chickens [5,6,12].
When injected at Eyal-Giladi and Kochav stage X, busul-
fan efficiently removed endogenous PGCs [11]. To our
knowledge, restoration of endogenous PGCs after busul-
fan treatment has not been reported to date.
In both sexes, the relative PGC ratios of the busulfan-
treated group to the normal embryos at 9 days were
markedly higher than that those at day 5.5. Also, sexu-
ally mature male and female chickens treated with bu-
sulfan at stage X were able to produce functional sperms
or eggs. These results indicated that germ cells were re-
covered from the cytotoxic effects of busulfan during de-
velopment. We thus hypothesized the existence of a
compensation mechanism to recover from busulfan tox-
icity in PGCs. To confirm the increase in PGCs after busul-
fan treatment, we conducted flow cytometry to enumerate
the increase in PGC number. The number of PGCs in the
busulfan treatment group recovered to ~60% that of the
control group. This suggested the existence of compensa-
tion and/or recovery mechanism in response to cytotoxicdamage in PGCs, which is one of the characteristics of
stem cells. A strong defensive mechanism against cytotoxic
damage has been demonstrated in various stem cells, in-
cluding spermatogonial stem cells [8] and embryonic stem
cells [19]. To determine whether this compensation is
caused by changes in the cell cycle, we conducted flow cy-
tometry with propidium iodide staining to discriminate
nonproliferating and proliferating PGCs after busulfan
treatment. The decrease in the proportion of G0/G1-phase
PGCs and the increase in that of S/G2/M-phase PGCs after
busulfan treatment indicated that the cell cycle status of
some PGC populations changed from quiescent (G0) to
proliferative (S/G2/M) phases. This change in cell cycle sta-
tus was further confirmed by the proliferation assay with
EdU incorporation. We found that the proportion of EdU-
positive cells among VASA-positive cells was significantly
higher in the busulfan-treated group.
Our results could be interpreted in two ways: first, a
subpopulation of PGCs with stem cell characteristics
proliferated, while the majority of PGCs underwent
apoptosis after busulfan treatment; or second, prolifera-
tion of existing PGCs after busulfan treatment suggested
Figure 6 Proliferation of primordial germ cells (PGCs) in 9-day-old embryonic gonads after busulfan treatment at stage X. To detect
proliferating PGCs, embryonic gonads were isolated at 9 days (4 hours after 5-ethynyl-2′-deoxyuridine (EdU) incorporation) and sectioned for stain-
ing with anti-VASA and EdU (A). Scale bars = 100 μm (common views) and 10 μm (magnified views). (B) Percentage of EdU-positive cells among
VASA-positive cells in the embryonic gonads. Four embryos were evaluated for both sexes. **P <0.01 and ***P <0.001, significant difference com-
pared with control.
Lee et al. Stem Cell Research & Therapy 2013, 4:136 Page 8 of 9
http://stemcellres.com/content/4/6/136that PGCs possess defensive mechanisms against cyto-
toxicity. Consistent with the first interpretation, there
exists a side population of PGCs in mice [20], which
have a greater ability to develop into pluripotent stem
cells [21]. In addition, side population cells that differen-
tiated from PGCs were enriched in spermatogonia of de-
veloping mice testes [22]. However, the relationship
between subpopulations of PGCs and proliferating PGCs
after cytotoxic effects was not investigated and little is
known about the existence of side population cells in
chicken germ cells. Consistent with the second interpret-
ation, conserved expression of several pluripotency-related
genes [23,24] and microRNAs [25] were identified in
PGCs. The potential of PGCs to transform intopluripotent embryonic germ cells [13,26] indicates that
PGCs maintain their undifferentiated state and stem cell
attributes in their genetic status. To understand the com-
pensation and/or restoration mechanisms of chicken
PGCs, it is necessary to characterize the proliferating PGC
subpopulation in busulfan-treated chicken gonads.
Conclusions
Our data suggest that endogenous PGCs can recover
from the cytotoxic effects of busulfan. The cell cycle sta-
tus of PGCs shifted to a lower proportion in the G0/G1
phase and a higher proportion in the S/G2/M phase after
busulfan treatment, which indicates that the recovery of
PGCs is strongly associated with the cell cycle transition.
Lee et al. Stem Cell Research & Therapy 2013, 4:136 Page 9 of 9
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vide an important basis for germ cell plantation studies.
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